Noble Capital Markets Initiates Equity Research Coverage on Cadrenal Therapeutics (CVKD)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Cadrenal Therapeutics today with his report titled "Addressing Unmet Anticoagulation Needs In Orphan Populations"
Noble Capital Markets Served as a selling agent to The GEO Group (GEO) in At-The-Market Offering
Noble Capital Markets is pleased to announce its role as a sales agent in The GEO Group, Inc.’s recently announced at-the-market offering of common stock. Under the program, GEO may offer and sell shares having an aggregate offering price of up to $300 million from time to time through a syndicate of sales agents. The transaction was announced on December 28, 2023, pursuant to a shelf registration declared effective on October 30, 2023.
Noble Capital Markets Initiates Research Coverage on AdTheorent (ADTH)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on AdTheorent today with his report titled "Positioned To Outshine Favorable Industry Growth"
Noble Capital Markets Initiates Equity Research Coverage on Xcel Brands (XELB)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Xcel Brands today with his report titled “Likely To Be The Trough Toward Improved Results"
Noble Capital Markets Initiates Equity Research Coverage on Eledon Pharmaceuticals (ELDN)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Eledon Pharmaceuticals today with his report titled "Initiating Coverage With An Outperform Rating and $10 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on QuantaSing Group Limited (QSG)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on QuantaSing Group today with his report titled "A Favorable Course For Revenue and Cash Flow Growth"
Noble Capital Markets Initiates Equity Research Coverage on Bitcoin Depot (BTM)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Bitcoin Depot today with his report titled "Initiating Coverage: Bringing Bitcoin To A "Store" Near You"
Noble Capital Markets Initiates Equity Research Coverage on The ODP Corporation (ODP)
Noble’s Equity Research Analyst Joe Gomes launched coverage on The ONE Group Hospitality today with his report titled “Initiation: Not Your Father's Office Depot"
Noble Capital Markets Initiates Equity Research Coverage on AZZ Inc. (AZZ)
Noble’s Equity Research AnalystMichael Heim launched coverage on AZZ Inc. today with his report titled "Initiating Coverage With an Outperform Rating and $60 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on Bit Digital (BTBT)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Bit Digital today with his report titled "Into the Digital Mines"
Noble Capital Markets Initiates Equity Research Coverage on Saga Communications, Inc. (SGA)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Saga Communications today with his report titled "Starts A New Chapter"
Noble Capital Markets Served as Co-Placement Agent to Eledon Pharmaceuticals (ELDN) in $180mm Private Placement.
Noble Capital Markets is pleased to announce its role as co-placement agent in connection with Eledon Pharmaceuticals, Inc.’s recently announced private placement of common stock and pre-funded warrants, which is expected to generate gross proceeds of approximately $185 million.
